nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A4—Thiotepa—sarcoma	0.112	0.156	CbGbCtD
Rivaroxaban—ABCB1—Dactinomycin—sarcoma	0.0901	0.125	CbGbCtD
Rivaroxaban—CYP3A5—Vincristine—sarcoma	0.0852	0.118	CbGbCtD
Rivaroxaban—ABCB1—Mitoxantrone—sarcoma	0.0806	0.112	CbGbCtD
Rivaroxaban—CYP3A5—Etoposide—sarcoma	0.0781	0.108	CbGbCtD
Rivaroxaban—ABCB1—Vincristine—sarcoma	0.0555	0.077	CbGbCtD
Rivaroxaban—ABCB1—Etoposide—sarcoma	0.0508	0.0706	CbGbCtD
Rivaroxaban—CYP3A4—Mitoxantrone—sarcoma	0.0483	0.0671	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—sarcoma	0.0347	0.0482	CbGbCtD
Rivaroxaban—CYP3A4—Vincristine—sarcoma	0.0332	0.0462	CbGbCtD
Rivaroxaban—CYP3A4—Etoposide—sarcoma	0.0304	0.0423	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—sarcoma	0.0208	0.0288	CbGbCtD
Rivaroxaban—F10—mammary gland—sarcoma	0.00331	0.151	CbGeAlD
Rivaroxaban—F10—hematopoietic system—sarcoma	0.00201	0.092	CbGeAlD
Rivaroxaban—F10—cardiac atrium—sarcoma	0.00153	0.0698	CbGeAlD
Rivaroxaban—CYP2J2—skin of body—sarcoma	0.00143	0.0655	CbGeAlD
Rivaroxaban—F10—tendon—sarcoma	0.00133	0.0609	CbGeAlD
Rivaroxaban—CYP2J2—cardiac atrium—sarcoma	0.00125	0.0572	CbGeAlD
Rivaroxaban—CYP2J2—uterus—sarcoma	0.00125	0.0569	CbGeAlD
Rivaroxaban—F10—testis—sarcoma	0.0011	0.0504	CbGeAlD
Rivaroxaban—CYP2J2—tendon—sarcoma	0.00109	0.0499	CbGeAlD
Rivaroxaban—F10—liver—sarcoma	0.00104	0.0476	CbGeAlD
Rivaroxaban—CYP2J2—testis—sarcoma	0.000904	0.0413	CbGeAlD
Rivaroxaban—CYP2J2—liver—sarcoma	0.000855	0.039	CbGeAlD
Rivaroxaban—F10—lymph node—sarcoma	0.0008	0.0365	CbGeAlD
Rivaroxaban—Chest pain—Mitoxantrone—sarcoma	0.000665	0.00258	CcSEcCtD
Rivaroxaban—Discomfort—Mitoxantrone—sarcoma	0.000657	0.00255	CcSEcCtD
Rivaroxaban—Renal failure acute—Epirubicin—sarcoma	0.000655	0.00254	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Vincristine—sarcoma	0.000655	0.00254	CcSEcCtD
Rivaroxaban—Oedema—Vincristine—sarcoma	0.000655	0.00254	CcSEcCtD
Rivaroxaban—Infection—Vincristine—sarcoma	0.000651	0.00252	CcSEcCtD
Rivaroxaban—Dyspepsia—Thiotepa—sarcoma	0.00065	0.00252	CcSEcCtD
Rivaroxaban—Nervous system disorder—Vincristine—sarcoma	0.000642	0.00249	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Doxorubicin—sarcoma	0.000641	0.00248	CcSEcCtD
Rivaroxaban—Oedema—Mitoxantrone—sarcoma	0.000638	0.00247	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Mitoxantrone—sarcoma	0.000638	0.00247	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Thiotepa—sarcoma	0.000638	0.00247	CcSEcCtD
Rivaroxaban—Fatigue—Thiotepa—sarcoma	0.000637	0.00247	CcSEcCtD
Rivaroxaban—Infection—Mitoxantrone—sarcoma	0.000634	0.00245	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Epirubicin—sarcoma	0.000633	0.00245	CcSEcCtD
Rivaroxaban—Fatigue—Dactinomycin—sarcoma	0.000632	0.00245	CcSEcCtD
Rivaroxaban—Constipation—Thiotepa—sarcoma	0.000632	0.00245	CcSEcCtD
Rivaroxaban—Pain—Thiotepa—sarcoma	0.000632	0.00245	CcSEcCtD
Rivaroxaban—Back pain—Etoposide—sarcoma	0.000629	0.00243	CcSEcCtD
Rivaroxaban—Shock—Mitoxantrone—sarcoma	0.000627	0.00243	CcSEcCtD
Rivaroxaban—Pain—Dactinomycin—sarcoma	0.000627	0.00243	CcSEcCtD
Rivaroxaban—Muscle spasms—Etoposide—sarcoma	0.000625	0.00242	CcSEcCtD
Rivaroxaban—Tachycardia—Mitoxantrone—sarcoma	0.000622	0.00241	CcSEcCtD
Rivaroxaban—Skin disorder—Mitoxantrone—sarcoma	0.000619	0.0024	CcSEcCtD
Rivaroxaban—Hypotension—Vincristine—sarcoma	0.000612	0.00237	CcSEcCtD
Rivaroxaban—Feeling abnormal—Thiotepa—sarcoma	0.000609	0.00236	CcSEcCtD
Rivaroxaban—Renal failure acute—Doxorubicin—sarcoma	0.000606	0.00235	CcSEcCtD
Rivaroxaban—Pain in extremity—Epirubicin—sarcoma	0.000605	0.00234	CcSEcCtD
Rivaroxaban—Osteoarthritis—Epirubicin—sarcoma	0.000605	0.00234	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000605	0.00234	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dactinomycin—sarcoma	0.000604	0.00234	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Thiotepa—sarcoma	0.000604	0.00234	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Etoposide—sarcoma	0.000603	0.00234	CcSEcCtD
Rivaroxaban—Anaemia—Etoposide—sarcoma	0.000601	0.00233	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dactinomycin—sarcoma	0.000599	0.00232	CcSEcCtD
Rivaroxaban—Hypotension—Mitoxantrone—sarcoma	0.000596	0.00231	CcSEcCtD
Rivaroxaban—Urticaria—Thiotepa—sarcoma	0.000587	0.00227	CcSEcCtD
Rivaroxaban—Malaise—Etoposide—sarcoma	0.000586	0.00227	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Doxorubicin—sarcoma	0.000586	0.00227	CcSEcCtD
Rivaroxaban—Abdominal pain—Thiotepa—sarcoma	0.000584	0.00226	CcSEcCtD
Rivaroxaban—CYP3A5—hematopoietic system—sarcoma	0.000581	0.0265	CbGeAlD
Rivaroxaban—Abdominal pain—Dactinomycin—sarcoma	0.000579	0.00224	CcSEcCtD
Rivaroxaban—Loss of consciousness—Etoposide—sarcoma	0.000571	0.00221	CcSEcCtD
Rivaroxaban—Dyspnoea—Mitoxantrone—sarcoma	0.000569	0.0022	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Epirubicin—sarcoma	0.000567	0.00219	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Vincristine—sarcoma	0.000565	0.00219	CcSEcCtD
Rivaroxaban—Fatigue—Vincristine—sarcoma	0.000565	0.00219	CcSEcCtD
Rivaroxaban—Dyspepsia—Mitoxantrone—sarcoma	0.000561	0.00217	CcSEcCtD
Rivaroxaban—Pain—Vincristine—sarcoma	0.00056	0.00217	CcSEcCtD
Rivaroxaban—Constipation—Vincristine—sarcoma	0.00056	0.00217	CcSEcCtD
Rivaroxaban—Osteoarthritis—Doxorubicin—sarcoma	0.00056	0.00217	CcSEcCtD
Rivaroxaban—Pain in extremity—Doxorubicin—sarcoma	0.00056	0.00217	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00056	0.00217	CcSEcCtD
Rivaroxaban—Chest pain—Etoposide—sarcoma	0.000553	0.00214	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Epirubicin—sarcoma	0.000553	0.00214	CcSEcCtD
Rivaroxaban—Fatigue—Mitoxantrone—sarcoma	0.00055	0.00213	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00055	0.00213	CcSEcCtD
Rivaroxaban—Discomfort—Etoposide—sarcoma	0.000547	0.00212	CcSEcCtD
Rivaroxaban—Pain—Mitoxantrone—sarcoma	0.000545	0.00211	CcSEcCtD
Rivaroxaban—Constipation—Mitoxantrone—sarcoma	0.000545	0.00211	CcSEcCtD
Rivaroxaban—Hypersensitivity—Thiotepa—sarcoma	0.000544	0.00211	CcSEcCtD
Rivaroxaban—Hypersensitivity—Dactinomycin—sarcoma	0.00054	0.00209	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Vincristine—sarcoma	0.000535	0.00207	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Etoposide—sarcoma	0.00053	0.00205	CcSEcCtD
Rivaroxaban—Asthenia—Thiotepa—sarcoma	0.00053	0.00205	CcSEcCtD
Rivaroxaban—Infection—Etoposide—sarcoma	0.000527	0.00204	CcSEcCtD
Rivaroxaban—Asthenia—Dactinomycin—sarcoma	0.000526	0.00204	CcSEcCtD
Rivaroxaban—Feeling abnormal—Mitoxantrone—sarcoma	0.000526	0.00203	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Doxorubicin—sarcoma	0.000524	0.00203	CcSEcCtD
Rivaroxaban—Pruritus—Thiotepa—sarcoma	0.000522	0.00202	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000522	0.00202	CcSEcCtD
Rivaroxaban—Tachycardia—Etoposide—sarcoma	0.000518	0.002	CcSEcCtD
Rivaroxaban—Abdominal pain—Vincristine—sarcoma	0.000518	0.002	CcSEcCtD
Rivaroxaban—Skin disorder—Etoposide—sarcoma	0.000515	0.002	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Doxorubicin—sarcoma	0.000511	0.00198	CcSEcCtD
Rivaroxaban—Angina pectoris—Epirubicin—sarcoma	0.000509	0.00197	CcSEcCtD
Rivaroxaban—Urticaria—Mitoxantrone—sarcoma	0.000507	0.00196	CcSEcCtD
Rivaroxaban—Diarrhoea—Thiotepa—sarcoma	0.000505	0.00196	CcSEcCtD
Rivaroxaban—Abdominal pain—Mitoxantrone—sarcoma	0.000504	0.00195	CcSEcCtD
Rivaroxaban—Diarrhoea—Dactinomycin—sarcoma	0.000501	0.00194	CcSEcCtD
Rivaroxaban—Hypotension—Etoposide—sarcoma	0.000496	0.00192	CcSEcCtD
Rivaroxaban—Dizziness—Thiotepa—sarcoma	0.000488	0.00189	CcSEcCtD
Rivaroxaban—Hypersensitivity—Vincristine—sarcoma	0.000482	0.00187	CcSEcCtD
Rivaroxaban—Dyspnoea—Etoposide—sarcoma	0.000473	0.00183	CcSEcCtD
Rivaroxaban—Angina pectoris—Doxorubicin—sarcoma	0.000471	0.00182	CcSEcCtD
Rivaroxaban—Hypersensitivity—Mitoxantrone—sarcoma	0.00047	0.00182	CcSEcCtD
Rivaroxaban—Asthenia—Vincristine—sarcoma	0.00047	0.00182	CcSEcCtD
Rivaroxaban—Vomiting—Thiotepa—sarcoma	0.00047	0.00182	CcSEcCtD
Rivaroxaban—Infestation—Epirubicin—sarcoma	0.000466	0.00181	CcSEcCtD
Rivaroxaban—Infestation NOS—Epirubicin—sarcoma	0.000466	0.00181	CcSEcCtD
Rivaroxaban—Vomiting—Dactinomycin—sarcoma	0.000466	0.0018	CcSEcCtD
Rivaroxaban—Rash—Thiotepa—sarcoma	0.000466	0.0018	CcSEcCtD
Rivaroxaban—Dermatitis—Thiotepa—sarcoma	0.000465	0.0018	CcSEcCtD
Rivaroxaban—Headache—Thiotepa—sarcoma	0.000463	0.00179	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000462	0.00179	CcSEcCtD
Rivaroxaban—Rash—Dactinomycin—sarcoma	0.000462	0.00179	CcSEcCtD
Rivaroxaban—Renal failure—Epirubicin—sarcoma	0.000458	0.00177	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Etoposide—sarcoma	0.000458	0.00177	CcSEcCtD
Rivaroxaban—Asthenia—Mitoxantrone—sarcoma	0.000458	0.00177	CcSEcCtD
Rivaroxaban—Fatigue—Etoposide—sarcoma	0.000457	0.00177	CcSEcCtD
Rivaroxaban—Jaundice—Epirubicin—sarcoma	0.000454	0.00176	CcSEcCtD
Rivaroxaban—Pain—Etoposide—sarcoma	0.000454	0.00176	CcSEcCtD
Rivaroxaban—Constipation—Etoposide—sarcoma	0.000454	0.00176	CcSEcCtD
Rivaroxaban—Urinary tract infection—Epirubicin—sarcoma	0.000453	0.00175	CcSEcCtD
Rivaroxaban—Diarrhoea—Vincristine—sarcoma	0.000448	0.00173	CcSEcCtD
Rivaroxaban—Haematuria—Epirubicin—sarcoma	0.000445	0.00172	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Epirubicin—sarcoma	0.000441	0.00171	CcSEcCtD
Rivaroxaban—Epistaxis—Epirubicin—sarcoma	0.00044	0.0017	CcSEcCtD
Rivaroxaban—Nausea—Thiotepa—sarcoma	0.000439	0.0017	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—sarcoma	0.000437	0.00169	CcSEcCtD
Rivaroxaban—Feeling abnormal—Etoposide—sarcoma	0.000437	0.00169	CcSEcCtD
Rivaroxaban—Diarrhoea—Mitoxantrone—sarcoma	0.000436	0.00169	CcSEcCtD
Rivaroxaban—CYP3A4—hematopoietic system—sarcoma	0.000436	0.0199	CbGeAlD
Rivaroxaban—Nausea—Dactinomycin—sarcoma	0.000435	0.00169	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—sarcoma	0.000435	0.00168	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Etoposide—sarcoma	0.000434	0.00168	CcSEcCtD
Rivaroxaban—Dizziness—Vincristine—sarcoma	0.000433	0.00168	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—sarcoma	0.000431	0.00167	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—sarcoma	0.000431	0.00167	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000428	0.00166	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—sarcoma	0.000424	0.00164	CcSEcCtD
Rivaroxaban—Urticaria—Etoposide—sarcoma	0.000421	0.00163	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—sarcoma	0.000421	0.00163	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—sarcoma	0.000421	0.00163	CcSEcCtD
Rivaroxaban—Abdominal pain—Etoposide—sarcoma	0.000419	0.00162	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—sarcoma	0.000419	0.00162	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—sarcoma	0.000419	0.00162	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—sarcoma	0.000419	0.00162	CcSEcCtD
Rivaroxaban—Vomiting—Vincristine—sarcoma	0.000416	0.00161	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—sarcoma	0.000413	0.0016	CcSEcCtD
Rivaroxaban—Rash—Vincristine—sarcoma	0.000413	0.0016	CcSEcCtD
Rivaroxaban—Dermatitis—Vincristine—sarcoma	0.000413	0.0016	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—sarcoma	0.000411	0.00159	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—sarcoma	0.000411	0.00159	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—sarcoma	0.00041	0.00159	CcSEcCtD
Rivaroxaban—Headache—Vincristine—sarcoma	0.00041	0.00159	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—sarcoma	0.000408	0.00158	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—sarcoma	0.000407	0.00158	CcSEcCtD
Rivaroxaban—Vomiting—Mitoxantrone—sarcoma	0.000405	0.00157	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—sarcoma	0.000405	0.00157	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—sarcoma	0.000403	0.00156	CcSEcCtD
Rivaroxaban—Rash—Mitoxantrone—sarcoma	0.000402	0.00156	CcSEcCtD
Rivaroxaban—Dermatitis—Mitoxantrone—sarcoma	0.000402	0.00156	CcSEcCtD
Rivaroxaban—Headache—Mitoxantrone—sarcoma	0.0004	0.00155	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—sarcoma	0.000396	0.00153	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—sarcoma	0.000391	0.00151	CcSEcCtD
Rivaroxaban—Hypersensitivity—Etoposide—sarcoma	0.000391	0.00151	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—sarcoma	0.000389	0.00151	CcSEcCtD
Rivaroxaban—Nausea—Vincristine—sarcoma	0.000389	0.00151	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—sarcoma	0.000388	0.0015	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—sarcoma	0.000387	0.0015	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—sarcoma	0.000387	0.0015	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—sarcoma	0.000382	0.00148	CcSEcCtD
Rivaroxaban—Asthenia—Etoposide—sarcoma	0.000381	0.00147	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—sarcoma	0.000381	0.00147	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—sarcoma	0.00038	0.00147	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—sarcoma	0.00038	0.00147	CcSEcCtD
Rivaroxaban—Nausea—Mitoxantrone—sarcoma	0.000379	0.00147	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—sarcoma	0.000378	0.00146	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—sarcoma	0.000377	0.00146	CcSEcCtD
Rivaroxaban—Pruritus—Etoposide—sarcoma	0.000375	0.00145	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—sarcoma	0.000366	0.00142	CcSEcCtD
Rivaroxaban—Diarrhoea—Etoposide—sarcoma	0.000363	0.00141	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—sarcoma	0.000362	0.0014	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—sarcoma	0.000359	0.00139	CcSEcCtD
Rivaroxaban—ABCB1—myometrium—sarcoma	0.000359	0.0164	CbGeAlD
Rivaroxaban—Back pain—Epirubicin—sarcoma	0.000352	0.00136	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—sarcoma	0.000351	0.00136	CcSEcCtD
Rivaroxaban—Dizziness—Etoposide—sarcoma	0.000351	0.00136	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—sarcoma	0.00035	0.00136	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—sarcoma	0.00035	0.00135	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—sarcoma	0.000349	0.00135	CcSEcCtD
Rivaroxaban—ABCB1—embryo—sarcoma	0.000346	0.0158	CbGeAlD
Rivaroxaban—Ill-defined disorder—Epirubicin—sarcoma	0.000338	0.00131	CcSEcCtD
Rivaroxaban—Vomiting—Etoposide—sarcoma	0.000337	0.00131	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—sarcoma	0.000337	0.0013	CcSEcCtD
Rivaroxaban—Rash—Etoposide—sarcoma	0.000334	0.0013	CcSEcCtD
Rivaroxaban—Dermatitis—Etoposide—sarcoma	0.000334	0.00129	CcSEcCtD
Rivaroxaban—Headache—Etoposide—sarcoma	0.000332	0.00129	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—sarcoma	0.000329	0.00127	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—sarcoma	0.000327	0.00127	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—sarcoma	0.000326	0.00126	CcSEcCtD
Rivaroxaban—ABCB1—seminal vesicle—sarcoma	0.000325	0.0148	CbGeAlD
Rivaroxaban—Muscle spasms—Doxorubicin—sarcoma	0.000324	0.00125	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—sarcoma	0.00032	0.00124	CcSEcCtD
Rivaroxaban—Nausea—Etoposide—sarcoma	0.000315	0.00122	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—sarcoma	0.000313	0.00121	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—sarcoma	0.000312	0.00121	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—sarcoma	0.00031	0.0012	CcSEcCtD
Rivaroxaban—ABCB1—hematopoietic system—sarcoma	0.000309	0.0141	CbGeAlD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000308	0.00119	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—sarcoma	0.000306	0.00119	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—sarcoma	0.000304	0.00118	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—sarcoma	0.000303	0.00117	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—sarcoma	0.000302	0.00117	CcSEcCtD
Rivaroxaban—CYP3A5—liver—sarcoma	0.000301	0.0137	CbGeAlD
Rivaroxaban—Anaphylactic shock—Epirubicin—sarcoma	0.000297	0.00115	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—sarcoma	0.000297	0.00115	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—sarcoma	0.000296	0.00115	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—sarcoma	0.000295	0.00114	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—sarcoma	0.000293	0.00113	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—sarcoma	0.000292	0.00113	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—sarcoma	0.00029	0.00112	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—sarcoma	0.000289	0.00112	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—sarcoma	0.000287	0.00111	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000285	0.0011	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—sarcoma	0.000284	0.0011	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—sarcoma	0.000281	0.00109	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—sarcoma	0.000278	0.00108	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—sarcoma	0.000275	0.00107	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—sarcoma	0.000275	0.00107	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—sarcoma	0.000273	0.00106	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—sarcoma	0.000271	0.00105	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—sarcoma	0.00027	0.00104	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—sarcoma	0.000269	0.00104	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—sarcoma	0.000267	0.00103	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—sarcoma	0.000265	0.00103	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—sarcoma	0.000262	0.00101	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—sarcoma	0.000257	0.000995	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—sarcoma	0.000257	0.000994	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—sarcoma	0.000256	0.000993	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—sarcoma	0.000254	0.000985	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—sarcoma	0.000254	0.000985	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—sarcoma	0.000245	0.00095	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—sarcoma	0.000245	0.000949	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—sarcoma	0.000243	0.000942	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—sarcoma	0.000242	0.000938	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000238	0.00092	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—sarcoma	0.000237	0.000918	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—sarcoma	0.000236	0.000915	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—sarcoma	0.000235	0.000911	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—sarcoma	0.000235	0.000911	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—sarcoma	0.000235	0.00091	CcSEcCtD
Rivaroxaban—ABCB1—uterus—sarcoma	0.000233	0.0106	CbGeAlD
Rivaroxaban—Feeling abnormal—Doxorubicin—sarcoma	0.000227	0.000878	CcSEcCtD
Rivaroxaban—CYP3A4—liver—sarcoma	0.000226	0.0103	CbGeAlD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—sarcoma	0.000225	0.000871	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—sarcoma	0.000219	0.000848	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—sarcoma	0.000219	0.000846	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—sarcoma	0.000218	0.000842	CcSEcCtD
Rivaroxaban—ABCB1—lymphoid tissue—sarcoma	0.000217	0.00992	CbGeAlD
Rivaroxaban—Asthenia—Epirubicin—sarcoma	0.000213	0.000826	CcSEcCtD
Rivaroxaban—Pruritus—Epirubicin—sarcoma	0.00021	0.000815	CcSEcCtD
Rivaroxaban—Diarrhoea—Epirubicin—sarcoma	0.000203	0.000788	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—sarcoma	0.000203	0.000785	CcSEcCtD
Rivaroxaban—ABCB1—bone marrow—sarcoma	0.000198	0.00903	CbGeAlD
Rivaroxaban—Asthenia—Doxorubicin—sarcoma	0.000197	0.000764	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—sarcoma	0.000197	0.000761	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—sarcoma	0.000195	0.000754	CcSEcCtD
Rivaroxaban—Vomiting—Epirubicin—sarcoma	0.000189	0.000732	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—sarcoma	0.000188	0.000729	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—sarcoma	0.000187	0.000726	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—sarcoma	0.000187	0.000725	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—sarcoma	0.000186	0.000721	CcSEcCtD
Rivaroxaban—Dizziness—Doxorubicin—sarcoma	0.000182	0.000704	CcSEcCtD
Rivaroxaban—Nausea—Epirubicin—sarcoma	0.000177	0.000684	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—sarcoma	0.000175	0.000677	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—sarcoma	0.000173	0.000672	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—sarcoma	0.000173	0.000671	CcSEcCtD
Rivaroxaban—Headache—Doxorubicin—sarcoma	0.000172	0.000667	CcSEcCtD
Rivaroxaban—ABCB1—testis—sarcoma	0.000169	0.00772	CbGeAlD
Rivaroxaban—Nausea—Doxorubicin—sarcoma	0.000163	0.000633	CcSEcCtD
Rivaroxaban—ABCB1—liver—sarcoma	0.00016	0.0073	CbGeAlD
Rivaroxaban—ABCB1—lymph node—sarcoma	0.000123	0.0056	CbGeAlD
